UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15b-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of: June 2020
Commission File Number: 000-51848
(Exact name of registrant as specified in its charter)
N/A
(Translation of Registrant’s name into English)
3500 – 1055 Dunsmuir Street PO Box 49114 Vancouver BC V7X1H7
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F x Form 40-F o
Indicate by check mark if the Registrant is submitting this Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes o No x
Indicate by check mark if the Registrant is submitting this Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes o No x
Indicate by check mark whether the registrant by furnishing the information contained in this Form 6-K is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934: Yes o No x
Exhibits
The following exhibits are included in this Form 6-K:
Exhibit No. | Description | Date filed on SEDAR |
99.1 | News Release, Avricore Health Signs Master Agreement to Pilot Healthtab TM Platform for Diabetes Management in Select Shoppers Drug Mart R Pharmacies | June 3, 2021 |
99.2 | News Release, Avricore Health Corporate Update Summer 2021 | June 9, 2021 |
99.3 | News Release, First Healthtab TM Testing Success in Shoppers Drug Marts Pilot Rollout | June 29, 2021 |
99.4 | News Release, Avricore Health CEO Hosts Investor Call July 6th | June 30, 2021 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: July 13, 2021 | AVRICORE HEALTH INC. |
|
|
| By: /s/ Kiki Smith |
| Kiki Smith |
| Chief Financial Officer |
2